Commonwealth Equity Services, LLC Citius Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.79 - $1.28 $158 - $256	200 Added 0.71%	28,254 $22,000
Q1 2022 May 04, 2022	SELL	$1.38 - $1.89 $393 - $538	-285 Reduced 1.01%	28,054 $50,000
Q4 2021 Jan 31, 2022	SELL	$1.51 - $2.2 $9,025 - $13,149	-5,977 Reduced 17.42%	28,339 $43,000
Q3 2021 Oct 29, 2021	BUY	$1.74 - $2.6 $59,709 - $89,221	34,316 New	34,316 $69,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $376M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.